Design, Synthesis, and Biological Activity of Amine-Type Cyclopentanepyridinone Derivatives as HIV‑1 Non-Nucleoside Reverse Transcriptase Inhibitors

Design, Synthesis, and Biological Activity of Amine-Type Cyclopentanepyridinone Derivatives as HIV‑1 Non-Nucleoside Reverse Transcriptase Inhibitors

Saved in:

Bibliographic Details
Main Authors:	Nancy Vanessa Castro-Perea, Gibran Rodríguez-Vega, Julio Cesar Abarca-Magaña, Mirna Berenice Ruiz-Rivera, José L. Medina-Franco, Leonor Huerta, Daniel Chávez
Format:	Article
Language:	English
Published:	American Chemical Society 2025-07-01
Series:	ACS Omega
Online Access:	https://doi.org/10.1021/acsomega.5c03953
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Lipidic strategy for improving bioavailability of nucleoside HIV reverse transcriptase inhibitor
by: N. S. Shastina, et al.
Published: (2011-04-01)

Dolutegravir Plus Two Nucleoside Reverse Transcriptase Inhibitors versus Efavirenz Plus Two Nucleoside Reverse Transcriptase Inhibitors As Initial Antiretroviral Therapy for People with HIV: A Systematic Review.
by: George W Rutherford, et al.
Published: (2016-01-01)

Efficacy and safety of novel russian non-nucleoside reverse transcriptase inhibitor elsulfavirine in combination with 2 nucleoside/nucleotide reverse transcriptase inhibitors in first-line HIV treatment – 96-week study
by: A. V. Kravchenko, et al.
Published: (2018-07-01)

Associations between plasma nucleoside reverse transcriptase inhibitors concentrations and cognitive function in people with HIV.
by: Davide De Francesco, et al.
Published: (2021-01-01)

Nelfinavir and Non-Nucleoside Reverse Transcriptase Inhibitor-Based Salvage Regimes in Heavily Hiv Pretreated Patients
by: Jean-Guy Baril, et al.
Published: (2003-01-01)

Sensitive assessment of the virologic outcomes of stopping and restarting non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.
by: Anna Maria Geretti, et al.
Published: (2013-01-01)

Pharmacokinetics of Etravirine Combined with Atazanavir/Ritonavir and a Nucleoside Reverse Transcriptase Inhibitor in Antiretroviral Treatment-Experienced, HIV-1-Infected Patients
by: Catherine Orrell, et al.
Published: (2015-01-01)

Identification of a novel small-molecule inhibitor of the HIV-1 reverse transcriptase activity with a non-nucleoside mode of action
by: Kyung-Lee Yu, et al.
Published: (2025-03-01)

DEVELOPMENT AND REGISTRATION OF A COMBINED DRUG FOR THE TREATMENT OF HIV INFECTION ON THE BASIS OF ON NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS (NRTI) PHOSPHAZIDE AND LAMIVUDINE
by: A. F. Khohlov, et al.
Published: (2019-01-01)

Spectrum of Non-Nucleoside Reverse Transcriptase Inhibitor-Associated Drug Resistance Mutations in Persons Living with HIV-1 Receiving Rilpivirine
by: Pavithra Nagarajan, et al.
Published: (2024-10-01)

Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Induced Neuropathy and Mitochondrial Toxicity: Limitations of the Poly-γ Hypothesis and the Potential Roles of Autophagy and Drug Transport
by: John Haynes, et al.
Published: (2024-12-01)

Bioisosterism-driven design of orally active, safe, and broad-spectrum biphenyl-DAPY derivatives as highly potent HIV-1 non-nucleoside reverse transcriptase inhibitors
by: Xiao-Mei Chen, et al.
Published: (2025-08-01)

QuEChERS and UPLC-MS/MS-Based Quantification of Human Plasma of Eight Nucleoside Reverse Transcriptase Inhibitors and Platinum Anticancer Drugs for Hepatocellular Carcinoma
by: Yanan Liu, et al.
Published: (2025-05-01)

Ritonavir-Boosted Darunavir Plus Two Nucleoside Reverse Transcriptase Inhibitors versus Other Regimens for Initial Antiretroviral Therapy for People with HIV Infection: A Systematic Review
by: Tatevik Balayan, et al.
Published: (2017-01-01)

Potential to use of viral reverse transcriptase inhibitors in oncology
by: O. A. Vlasova, et al.
Published: (2024-06-01)

The Emerging Role of Telomerase Reverse Transcriptase in Mitochondrial DNA Metabolism
by: Donna M. Gordon, et al.
Published: (2010-01-01)

Diversity of reverse-transcriptase-containing viruses through global metagenomics
by: Kaiyang Zheng, et al.
Published: (2025-01-01)

Apparent non-canonical trans-splicing is generated by reverse transcriptase in vitro.
by: Jonathan Houseley, et al.
Published: (2010-08-01)

Reverse transcriptase inhibitors diminish systemic proinflammatory responses to bacterial pathogens
by: Karthik Hullahalli, et al.
Published: (2025-02-01)

HIV-1 protease and reverse transcriptase control the architecture of their nucleocapsid partner.
by: Gilles Mirambeau, et al.
Published: (2007-08-01)

Small Dumbbell Oligonucleotides Inhibitors of RNase H Activity of MOMULV Reverse Transcriptase
by: Ajay Kumar
Published: (2011-01-01)

Promoted read-through and mutation against pseudouridine-CMC by an evolved reverse transcriptase
by: Zhiyong He, et al.
Published: (2025-01-01)

Next-Generation Sequencing Methods to Determine the Accuracy of Retroviral Reverse Transcriptases: Advantages and Limitations
by: Javier Martínez del Río, et al.
Published: (2025-01-01)

Epigenetic perturbation driving asleep telomerase reverse transcriptase: Possible therapeutic avenues in carcinoma
by: Ajay Kumar, et al.
Published: (2017-03-01)

Lyophilised Reverse Transcriptase and Polymerase for Point‐of‐Care Diagnostics of SARS‐CoV‐2
by: Natalie Mutter, et al.
Published: (2025-07-01)

Adaptation of the Fluorogenic 5′-Nuclease Chemistry to a PCR-Based Reverse Transcriptase Assay
by: Tom Maudru, et al.
Published: (1998-12-01)

Enhancing the reverse transcriptase function in Taq polymerase via AI-driven multiparametric rational design
by: Yulia E. Tomilova, et al.
Published: (2024-12-01)

Immobilized Nucleoside 2′-Deoxyribosyltransferases from Extremophiles for Nucleoside Biocatalysis
by: Saúl Antonio Hernández Martínez, et al.
Published: (2024-12-01)

Comparison of Commercially Available Thermostable DNA Polymerases with Reverse Transcriptase Activity in Coupled Reverse Transcription Polymerase Chain Reaction Assays
by: Evgeniya V. Smirnova, et al.
Published: (2025-01-01)

A novel variant of telomerase reverse transcriptase (TERT) associated with risk of glioma in a Korean population
by: Ho Yeon Lim, et al.
Published: (2025-04-01)

Interactions between HIV-1 reverse transcriptase and the downstream template strand in stable complexes with primer-template.
by: Wiriya Rutvisuttinunt, et al.
Published: (2008-01-01)

Prediction of mutational tolerance in HIV-1 protease and reverse transcriptase using flexible backbone protein design.
by: Elisabeth Humphris-Narayanan, et al.
Published: (2012-01-01)

A polymorphism at position 400 in the connection subdomain of HIV-1 reverse transcriptase affects sensitivity to NNRTIs and RNaseH activity.
by: David W Wright, et al.
Published: (2013-01-01)

Predictive Efficacy of Dual Therapies Combining Integrase Strand Transfer Inhibitors with Second-Generation Non-Nucleoside Reverse Transcriptase Inhibitors Following HIV-1 Treatment Failure in Cameroon: Implications for the Use of a Long-Acting Therapeutic Strategy in Low- and Middle-Income Countries
by: Davy-Hyacinthe Gouissi Anguechia, et al.
Published: (2024-11-01)

Current Use of Nucleoside Analogues in the Treatment of HIV Infection
by: Julio SG Montaner, et al.
Published: (1994-01-01)

Genogroup-Specific Multiplex Reverse Transcriptase Loop-Mediated Isothermal Amplification Assay for Point-of-Care Detection of Norovirus
by: Wahedul Karim Ansari, et al.
Published: (2025-07-01)

An Exploratory Pharmacogenetic Pilot Study of Two Reverse Transcriptase Inhibitors, Tenofovir Alafenamide Fumarate and Tenofovir Disoproxil Fumarate
by: Derek E. Murrell, et al.
Published: (2025-05-01)

Value of Rapid Antigen Test in Comparison with Reverse Transcriptase-Polymerase Chain Reaction Method in the Diagnosis of COVID-19
by: Alireza MIRAHMADIZADEH, et al.
Published: (2022-03-01)

Development of 3D Cell-Based Fluorescent Reporter Assay for Screening of Drugs Downregulating Telomerase Reverse Transcriptase
by: You Li, et al.
Published: (2025-03-01)

5′-Guanidino Xylofuranosyl Nucleosides as Novel Types of 5′-Functionalized Nucleosides with Biological Potential
by: Jennifer Szilagyi, et al.
Published: (2025-05-01)